Your browser doesn't support javascript.
loading
Circulating tumour DNA analyses reveal novel resistance mechanisms to CDK inhibition in metastatic breast cancer.
Abbosh, C; Swanton, C; Birkbak, N J.
Affiliation
  • Abbosh C; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK.
  • Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK; Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK.
  • Birkbak NJ; Cancer Research UK Lung Cancer Centre of Excellence, London and Manchester; University College London Cancer Institute, London, UK; Translational Cancer Therapeutics Laboratory, The Francis Crick Institute, London, UK. Electronic address: nicolai.birkbak@crick.ac.uk.
Ann Oncol ; 29(3): 535-537, 2018 03 01.
Article in En | MEDLINE | ID: mdl-29351578
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Circulating Tumor DNA Limits: Humans Language: En Journal: Ann Oncol Year: 2018 Document type: Article